Cost-Effectiveness Analysis of Genotype-Guided Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention in Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-Effectiveness Analysis of Genotype-Guided Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention in Korea

Published:2024-03-31 Issue:1 Volume:3 Page:51-61
ISSN:2951-3359
Container-title:Drug Targets and Therapeutics
language:en
Short-container-title:DTT

Author:

Suh Hae Sun¹²³^ORCID,Lee Iyn-Hyang⁴,Lee Sukhyang⁵,Kang Hye-Young⁶

Affiliation:

1. College of Pharmacy, Kyung Hee University, Seoul, Korea

2. Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Korea

3. Institute of Regulatory Innovation through Science, Kyung Hee University, Seoul, Korea

4. College of Pharmacy, Yeungnam University, Gyeongsan, Korea

5. College of Pharmacy, Ajou University, Suwon, Korea

6. College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Korea

Funder

Korea Food and Drug Administration

Ministry of Food and Drug Safety

Publisher

Drug Targets and Therapeutics (DTT) - Pharmaceutical Society of Korea

Link

https://pdf.medrang.co.kr/DTT/2024/003/dtt-3-1-51.pdf

Reference41 articles.

1. Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar

2. Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions

3. Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry

4. Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

5. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3